Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Drug Deliv Transl Res. 2013 Jan 9;3(4):299–308. doi: 10.1007/s13346-012-0124-9

Figure 1.

Figure 1

Showing the basic characterization of the PEGylated PLGA nanoparticles encapsulating doxorubicin: Nanoparticles morphology and size measurement by (a) representative TEM image, Inset: high magnification image of individual nanoparticles, (b) distribution profile as measured by DLS.